Literature DB >> 24585574

Cutaneous metastases during an aggressive course of Xp11.2 translocation renal cell carcinoma in a teenager.

Helene Sudour-Bonnange1, Xavier Leroy, Marie-Pierre Chauvet, Marion Classe, P M Robin, Pierre Leblond.   

Abstract

We reported a rare case of cutaneous metastases of renal cell carcinoma (RCC) with an Xp11.2 translocation in a 15-year-old female. Clinicians should be aware of the possibility of this uncommon site of metastasis, which can indicate multivisceral dissemination of the disease. We discuss the feasibility and opportunity of treating such a patient with multiple line of tyrosine kinase inhibitor (TKI) targeting vascular endothelial and platelet-derived growth factor receptors.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Xp11.2 RCC; cutaneous metastasis; teenager; tyrosine kinase inhibitors

Mesh:

Substances:

Year:  2014        PMID: 24585574     DOI: 10.1002/pbc.25015

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  A case of metastatic Xp11.2 translocation renal cell carcinoma successfully managed by cytoreductive nephrectomy followed by axitinib therapy.

Authors:  Koichi Nishimura; Toshio Takagi; Naohiro Toda; Tomoko Yamamoto; Tsunenori Kondo; Hideki Ishida; Yoji Nagashima; Kazunari Tanabe
Journal:  Mol Clin Oncol       Date:  2017-01-31

2.  Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: A case report.

Authors:  Xiang Pan; Jing Quan; Liwen Zhao; Wenhua Li; Benlin Wei; Shangqi Yang; Yongqing Lai
Journal:  Mol Clin Oncol       Date:  2017-11-13

Review 3.  Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies.

Authors:  Xiangming Cheng; Weidong Gan; Gutian Zhang; Xiaogong Li; Hongqian Guo
Journal:  BMC Urol       Date:  2016-07-11       Impact factor: 2.264

4.  Factors Associated with Survival From Xp11.2 Translocation Renal Cell Carcinoma Diagnosis-A Systematic Review and Pooled Analysis.

Authors:  Yuqing Wu; Saisai Chen; Minhao Zhang; Kuangzheng Liu; Jibo Jing; Kehao Pan; Lihua Zhang; Bin Xu; Xiaoming Lu; Ming Chen
Journal:  Pathol Oncol Res       Date:  2021-03-30       Impact factor: 3.201

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.